Verici Dx plc (LSE: VRCI) Stock Analysis & Fundamentals | ScreenerHero

Create free account

VRCIVerici Dx plc

LSE · GB · Healthcare · Diagnostics & Research · vericidx.com

0.3750GBp0.00%Mkt Cap: 9.02M $P/E: —1d ago

Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transp…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Higher

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap9.02M $

Enterprise Value-3.48M $

Revenue (TTM)3.98M $

Gross Profit3.08M $

Net Income (TTM)-7.54M $

Revenue/Share0.5174 USD

Last Price0.3750 GBp

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA0.50

EV/Revenue-0.87

P/S2.27

P/B0.49

EPS (TTM)-0.01

EPS (Forward)0.00

52W Range

0.33005% of range1.250

52W High1.250 GBp

52W Low0.3300 GBp

Profitability

Gross Margin77.46%

Oper. Margin-221.13%

EBITDA Margin-174.78%

Profit Margin-189.22%

ROE-117.81%

ROA-56.47%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.54M $

CapEx (TTM)209.78K $

FCF Margin-159.24%

FCF Yield-70.29%

Net Debt-3.52M $

Net Debt/EBITDA0.50

Balance Sheet

Debt/Equity0.07

Current Ratio3.94

Quick Ratio3.94

Book Value/Sh0.0076 GBp

Cash/Share0.4340 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)2.900 GBp

Upside (mean)+673.3%

Target Range2.900 GBp – 2.900 GBp

# Analysts1

Ownership

Shares Out.2.21B

Float4.96M

Insiders2.56%

Institutions60.80%

Technical

SMA 500.4317 (-13.1%)

SMA 2000.6206 (-39.6%)

Beta—

S&P 52W Chg20.05%

Avg Vol (30d)1.57M

Avg Vol (10d)893.45K

Technical Indicators

RSI (14)22.6

MACD-0.0169

MACD Signal-0.0201

MACD Hist.+0.0032

BB Upper0.4210 GBp

BB Middle0.3837 GBp

BB Lower0.3465 GBp

BB Width19.42%

ATR (14)0.0468 GBp

Vol Ratio (20d)0.27x